The global metabolism assays market is poised for steady expansion, driven by the convergence of advanced biotechnology, increasing prevalence of metabolic disorders, and rising investments in drug discovery. Valued at US$ 1.5 Bn in 2023, the market is projected to grow at a CAGR of 6.7% from 2024 to 2034, surpassing US$ 3.1 Bn by the end of 2034. Analysts’ Viewpoint The metabolism...